Myrrh Essential Oil Improves DSS-Induced Colitis by Modulating the MAPK Signaling Pathway: In vitro and in vivo Studies
Tiantian Tang,Yujiao Wang,Taotao Li,Ding Liu,Kai Yang,Jing Sun,Yajun Shi,Dongyan Guo,Junbo Zou,Fengyun Bai,Ying Sun,Mei Wang,Xiaofei Zhang
DOI: https://doi.org/10.2147/jir.s473596
IF: 4.5
2024-08-02
Journal of Inflammation Research
Abstract:Tiantian Tang, 1, 2, &ast Yujiao Wang, 1, 2, &ast Taotao Li, 1, 2, &ast Ding Liu, 1, 2 Kai Yang, 1, 2 Jing Sun, 1, 2 Yajun Shi, 1, 2 Dongyan Guo, 1, 2 Junbo Zou, 1, 2 Fengyun Bai, 3 Ying Sun, 3 Mei Wang, 1, 2 Xiaofei Zhang 1, 2 1 Key Laboratory of Basic and New Drug Research in Chinese Medicine, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, People's Republic of China; 2 Shaanxi Provincial University Engineering Research Center of Chinese Medicine Aromatic Industry, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, People's Republic of China; 3 Shaanxi Dongtai Pharmaceutical Co., Ltd., Xianyang, Shaanxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Mei Wang; Xiaofei Zhang, Key Laboratory of Basic and New Drug Research in Chinese Medicine; Shaanxi Provincial University Engineering Research Center of Chinese Medicine Aromatic Industry, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, People's Republic of China, Email ; Objective: To explore the mechanism and active components of the anti-colitis effects of myrrh essential oil (MEO). Methods: In this study, we investigated the anti-inflammatory effects and molecular mechanisms of MEO on dextran sulfate sodium (DSS)-induced colitis with in vitro cell experiments, RNA-seq (RNA Sequencing), Weighted gene co-expression network analysis (WGCNA), combined with "weighting coefficient" network pharmacology, as and in vivo pharmacodynamic experiments. A 3% DSS solution was used to induce colitis in BALB/c mice and MEO was administered orally. We performed gas chromatography-mass spectrometry (GC-MS) analysis of the MEO components. The disease activity index (DAI) was evaluated by observing body weight, fecal characteristics, and blood in the stool of mice. The levels of inflammatory cytokines (TNF-α and IL-1β) in mouse serum were measured using ELISA (Enzyme-linked immunosorbent assay) kits. Additionally, the expression of MAPK-related proteins (JNK, p-JNK, ERK, and p-ERK) in mouse colonic tissues was detected by Western blotting and immunohistochemistry. Results: MEO (0.0625– 0.125μg/g, p.o). significantly inhibited the expression of the inflammatory mediator Nitric oxide (NO) in lipopolysaccharide (LPS)-induced RAW264.7 macrophages. After treatment, there was a significant increase in body weight and alleviation of diarrhea and bloody stools in colitis mice. It also reduced inflammatory cell infiltration. Furthermore, it decreased the serum levels of TNF-α and IL-1β, and reduced the activity of p-JNK and p-ERK in the MAPK pathway. Conclusion: MEO relieved DSS-induced colitis by modulating the MAPK pathway. The experimental results indicate that the MAPK pathway might be inhibited by the synergistic effect of gamma-Muurolene, Curzerene, beta-Elemene, and Furanoeudesma 1.3-diene in MEO, which provides a novel idea for subsequent research and development of new anti-colitis drugs. Keywords: colitis, myrrh essential oil, MAPK signaling pathway, RNA sequencing, weighted gene co-expression network analysis Graphical Colitis is a nonspecific chronic inflammatory disease of the intestine with a high rate of recurrence and cancer of the digestive system. 1 Patients with colitis mainly present with symptoms such as diarrhea, mucus in stool, pus, and blood in stool. 2 Some studies have reported that approximately 30% of colitis require colectomy. 3 Most of the clinical drugs currently used to alleviate the symptoms of colitis are salicylic acid agents, immunosuppressive agents, and biological agents. However, these drugs generally have many adverse effects, leading to easy disease recurrence, are costly, and have poor patient compliance. 4 Currently, the research value of "aromatherapy", which uses essential oil extracts from aromatic plants for therapeutic purposes, is increasing in medicine because of the anti-inflammatory, antibacterial, and antioxidant effects of plant-based oil. 5 Therefore, in this study, we considered aromatherapy a potential therapeutic approach for treating colitis. Myrrh ( Commiphora myrrha ), obtained from trees or shrubs of the genus Commiphora ( Burseraceae ), is an aromatic oleogum resin. 6 The chemical composition of myrrh is complex and diverse, mainly including resin, gum, essential oil, salts and acids, 7 among which essential oil is the char -Abstract Truncated-
immunology